Citation

Henderson JA, Bilimoria D, Bubenik M, Cadilhac C, Cottrell KM, Dietrich E, Denis F, Ewing N, Falardeau G, Giroux S, Grey R, L'Heureux L, Liu B, Mani N, Morris M, Nicolas O, Pereira OZ, Poisson C, Govinda Rao B, Reddy TJ, Selliah S, Shawgo RS, Vaillancourt L, Wang J, Yannopoulos CG, Chauret N, Berlioz-Seux F, Chan LC, Das SK, Grillot AL, Bennani YL, Maxwell JP.: Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potency. Bioorg Med Chem Lett, Volume 25 (4), 2015

Authors

Bennani YL, Berlioz-Seux F, Bilimoria D, Bubenik M, Cadilhac C, Chan LC, Chauret N, Cottrell KM, Das SK, Denis F, Dietrich E, Ewing N, Falardeau G, Giroux S, Govinda Rao B, Grey R, Grillot AL, Henderson JA, L'Heureux L, Liu B, Mani N, Maxwell JP., Morris M, Nicolas O, Pereira OZ, Poisson C, Reddy TJ, Selliah S, Shawgo RS, Vaillancourt L, Wang J, Yannopoulos CG

Journal

Bioorg Med Chem Lett

Year

2015

DOI

10.1016/j.bmcl.2014.12.045

PubMed

25577041

Machine-readable

REST APIRDF